Recommendations for essential medicines for multiple sclerosis in low-resource settings
Recommendations for the minimum essential DMTs for MS in low-resource settings were developed based on robust consideration of evidence and relevant context.
Authors
- Simona Vecchi (ORCID: https://orcid.org/0000-0002-3893-8403)
- Janis Siew Noi Tye
- Maya Zeineddine (ORCID: https://orcid.org/0000-0002-6842-5609)
- Guy Peryer (ORCID: https://orcid.org/0000-0003-0425-6911)
- Shanthi Viswanathan (ORCID: https://orcid.org/0000-0002-0094-0540)
- DK Chawla
- Dina Jacobs (ORCID: https://orcid.org/0009-0005-6555-8712)
- Nick Rijke (ORCID: https://orcid.org/0000-0002-0328-1309)
- Anne Helme (ORCID: https://orcid.org/0000-0001-8880-2347)
- Tomáš Kalinčík (ORCID: https://orcid.org/0000-0003-3778-1376)
- Irene Tramacere (ORCID: https://orcid.org/0000-0001-5550-3412)
- Graziella Filippini
- Anthony Traboulsee (ORCID: https://orcid.org/0000-0002-0351-9639)
- Ben Ridley (ORCID: https://orcid.org/0000-0003-4868-6681)
- Marien González‐Lorenzo (ORCID: https://orcid.org/0000-0002-0872-3858)
- Aukje K. Mantel‐Teeuwisse (ORCID: https://orcid.org/0000-0002-8782-0698)
- Deanna R. Saylor (ORCID: https://orcid.org/0000-0002-9297-0244)
- Silvia Minozzi (ORCID: https://orcid.org/0000-0003-0471-8581)
- Riley M. Bove (ORCID: https://orcid.org/0000-0002-2034-8800)
- Francesco Nonino (ORCID: https://orcid.org/0000-0003-3601-6381)
- Oluwadamilola O. Ojo (ORCID: https://orcid.org/0000-0001-6461-2653)
- Elisa Baldin (ORCID: https://orcid.org/0000-0002-3277-5623)
- Joanna Laurson-Doube (ORCID: https://orcid.org/0000-0001-9619-9170)
- Cinzia Del Giovane (ORCID: https://orcid.org/0000-0002-5028-932X)
- Dilraj Sokhi (ORCID: https://orcid.org/0000-0002-8819-0851)
- Matteo Foschi (ORCID: https://orcid.org/0000-0002-0321-7155)
- Thomas Piggott (ORCID: https://orcid.org/0000-0003-1643-5386)
- Kathleen Costello
- Holger J. Schünemann (ORCID: https://orcid.org/0000-0003-3211-8479)
- Emanuela Pasi
- Jennifer McDonell
- Jagannadha Avasarala (ORCID: https://orcid.org/0000-0002-2322-503X)
- Cárlos Navas (ORCID: https://orcid.org/0000-0002-0472-3930)
- Ivan Bogdanović (ORCID: https://orcid.org/0000-0003-0055-5201)
- Feng Xie (ORCID: https://orcid.org/0000-0003-3454-6266)
- B. Ozcan (ORCID: https://orcid.org/0000-0002-6385-9088)
- Tapas Kumar Banerjee (ORCID: https://orcid.org/0000-0002-6923-7909)
- Najoua El Abkari
- Andrea Prato Chichiraldi
Institutions
- University of East Anglia (GB)
- University of Bern (CH)
- University of Modena and Reggio Emilia (IT)
- The Royal Melbourne Hospital (AU)
- Humanitas University (IT)
- University of British Columbia (CA)
- University of Kentucky (US)
- Johns Hopkins University (US)
- Inserm (FR)
- The University of Melbourne (AU)
- University of California, San Francisco (US)
- Utrecht University (NL)
- Mario Negri Institute for Pharmacological Research (IT)
- University of Lagos (NG)
- Queen's University (CA)
- University of L'Aquila (IT)
- Multiple Sclerosis Foundation (US)
- Hospital Kuala Lumpur (MY)
- Lagos University Teaching Hospital (NG)
- Multiple Sclerosis Society of Canada (CA)
- Multiple Sclerosis International Federation (GB)
- University Teaching Hospital (ZM)
- University of Zambia (ZM)
- National Neurosciences Centre (IN)
- Can Do Multiple Sclerosis (US)
- Aga Khan University Nairobi (KE)
- Istituto delle Scienze Neurologiche di Bologna (IT)
- National Neuroscience Institute (SG)
- MSD (Serbia) (RS)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Impact (CA)
- Hospital Universitario Infantil San José (CO)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- The Patients Association (GB)
- Institut de Recherche pour le Développement (FR)
- Université de Limoges (FR)
- University of Pennsylvania (US)
- McMaster University (CA)
Publication Details
- Journal
- Multiple Sclerosis Journal
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1177/13524585241308134
- Citations
- 2
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 2.26